Entera Bio (ENTX) Deferred Taxes (2021 - 2024)

Entera Bio's (ENTX) quarterly Deferred Taxes came in at $14000.0 in Q4 2024, down 51.72% on a QoQ basis from $29000.0 in Q3 2023.

Entera Bio (ENTX) Deferred Taxes (2021 - 2024) Analysis & Trends

Entera Bio (ENTX) has 4 years of Deferred Taxes data on file, last reported at $14000.0 in Q4 2024.

Quarterly Deferred Taxes changed N/A year-over-year to $14000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $43000.0 (up 48.28% YoY) and the FY2024 annual result came in at $14000.0, down 51.72% from the prior year.
Deferred Taxes eased to $14000.0 in Q4 2024, from $29000.0 in the prior quarter.
In the past five years, Deferred Taxes ranged from a high of $214000.0 in Q3 2022 to a low of -$57000.0 in Q2 2021.
A 4-year average of $0.0 and a median of -$31500.0 in 2022 frame the typical range for Deferred Taxes.
Annual changes were most pronounced in 2022 — Deferred Taxes soared 475.44% — and 2023, when it tumbled 86.45%.
Tracing ENTX's Deferred Taxes over 4 years: stood at -$51000.0 in 2021, then soared by 145.1% to $23000.0 in 2022, then rose by 26.09% to $29000.0 in 2023, then slumped by 51.72% to $14000.0 in 2024.
The last three Deferred Taxes figures came in at $14000.0 (Q4 2024), $29000.0 (Q3 2023), and $23000.0 (Q4 2022), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Deferred Taxes (Qtr)
1	Vertex Pharmaceuticals	139.35 Bn	131.50 Bn	2.84 Bn	-69.70 Mn
2	Regeneron Pharmaceuticals	86.12 Bn	78.12 Bn	3.93 Bn	194.40 Mn
3	Argenx Se	65.22 Bn	60.03 Bn	1.37 Bn	-
4	Moderna	58.98 Bn	53.84 Bn	52.00 Mn	-
5	BeOne Medicines	42.08 Bn	36.99 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.61 Bn	28.30 Bn	992.69 Mn	2.66 Mn
7	BioNTech SE	27.98 Bn	9.59 Bn	668.28 Mn	-
8	Insmed	27.46 Bn	26.30 Bn	358.27 Mn	-
9	Royalty Pharma	27.30 Bn	26.47 Bn	-	-
10	Entera Bio	166.99 Mn	155.68 Mn	-	-

Download Data